Articles by Reflector - Pharmaceutical Executive

ADVERTISEMENT

Articles by Reflector

TTIP: From Hot Tip to Oblivion?

Aug 18, 2014

The Transatlantic Trade and Investment Partnership (TTIP) was the hot tip for a 2014 success story. But as summer slides away, the latest read-out of progress suggests that rather than remaining a hot tip, TTIP is now risking oblivion...

EFPIA's 'Integrated Strategy' in Europe: Out of the Frying Pan, Into the Fire?

Aug 1, 2014

Industry's grand vision for reshaping the life sciences in Europe may ultimately prove to be a lost cause.

Europe Gears Up to Attack Counterfeit Medicines—But Only Some of Them

Jul 1, 2014

Cross-sector partnership seeks support for a pan-European system to keep fake drugs out, but obstacles are many.

Hopes High as EU Heads Into Leadership Change

Jun 1, 2014

Rare allies—innovator and generic pharmas—are calling for policy integration in Europe. But ideology and newfound scepticism on the merits of drugs in healthcare could complicate the effort.

Rebuilding European Pharma's Competitive Agenda

May 19, 2014

Because of the tougher conditions they face and shifts in ownership and corporate strategy, EFPIA and EGA have started to work together much more closely.

European Clinical Trials: The Die Is Cast

Apr 15, 2014

Politicians and health campaigners are celebrating the final agreement of the EU's new clinical trials rules. But the European drug industry is not so euphoric, writes Reflector.

Whatever Happened To Faster Reimbursement For Generics In Europe?

Apr 1, 2014

The plan to accelerate generic pricing and reimbursement has become another tragic European casualty.

Italian Ruling on Roche and Novartis Resonates Across Europe

Mar 24, 2014

Roche and Novartis have been fined in Italy on pricing conspiracy charges, fueling a wider debate in Europe about expenditure, efficiency and off-label prescribing.

Growing Pains: The European Medicines Agency at 20

Feb 3, 2014

Reflector looks at the growing pains of the European Medicine Agency (EMA) as it faces the key policy challenges of 2014.

ADVERTISEMENT

Click here